Evora
Evora Biosciences leverages the therapeutic properties of exosomes to build the next generation of cell therapies.
Niveau de maturité
- Idéation
- R&D
- Minimum viable product
- 1er client / 1ers utilisateurs
- Commercialisation
L’histoire
Evora Biosciences develops EVOGEX, a proprietary therapeutic discovery platform for exosome-based treatments.
Our off-the-shelf exosomes are engineered for improved efficacy, and we aim to disrupt the field of regenerative medicine and beyond.